Cavalier Investments’s Inogen INGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
– Sell
-2,150
Closed -$267K – 141
2018
Q4
$267K Hold
2,150
– – 0.09% 135
2018
Q3
$525K Buy
+2,150
New +$497K 0.15% 115
2016
Q1
– Sell
-15,300
Closed -$613K – 116
2015
Q4
$613K Hold
15,300
– – 0.36% 52
2015
Q3
$743K Buy
+15,300
New +$726K 0.62% 27

Other funds holding INGN

Cavalier Investments's INGN Position: Q1 2019 in Review

Cavalier Investments sold out of Inogen (INGN) in Q1 2019, closing a stake of 2,150 shares — an estimated $267K sold.

Cavalier Investments first reported a position in INGN in Q3 2015 and held it in 4 quarters. The position peaked at $743K in Q3 2015. 239 funds tracked by Wall St. Rank hold INGN as of Q1 2019.

  • Cavalier Investments reported no remaining Inogen position as of Q1 2019 after selling out during the quarter.
  • Cavalier Investments sold 2,150 Inogen shares in Q1 2019, an estimated $267K.
  • Cavalier Investments first reported a position in Inogen in Q3 2015 and held it in 4 quarters.
  • Cavalier Investments's Inogen position peaked at $743K in Q3 2015.
  • 239 funds tracked by Wall St. Rank held Inogen as of Q1 2019.

Based on Cavalier Investments's 13F filing for Q1 2019, filed 3 May 2019.